Advisors Preferred’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,188
Closed -$140K 139
2019
Q4
$140K Buy
+2,188
New +$125K 0.04% 123
2016
Q1
Sell
-321
Closed -$22K 217
2015
Q4
$22K Buy
+321
New +$21.2K 0.01% 129

Other funds holding BMY

Advisors Preferred's BMY Position: Q1 2020 in Review

Advisors Preferred sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 2,188 shares — an estimated $140K sold.

Advisors Preferred first reported a position in BMY in Q4 2015 and held it in 2 quarters. The position peaked at $140K in Q4 2019. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Advisors Preferred reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Advisors Preferred sold 2,188 Bristol-Myers Squibb shares in Q1 2020, an estimated $140K.
  • Advisors Preferred first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 2 quarters.
  • Advisors Preferred's Bristol-Myers Squibb position peaked at $140K in Q4 2019.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Advisors Preferred's 13F filing for Q1 2020, filed 20 Apr 2020.